Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study
2018
Introduction
Rituximab is considered as a potential therapeutic option in relapsing-remitting (RRMS) and progressive forms (PMS) of multiple sclerosis (MS).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
25
References
28
Citations
NaN
KQI